Status:
COMPLETED
Impact of Glistenings in AcrySof Intraocular Lenses on Visual Quality
Lead Sponsor:
University of Utah
Conditions:
Lenses, Intraocular
Glistenings
Eligibility:
All Genders
Brief Summary
This study will assess the impact of IOL glistenings on visual quality and function in patients implanted with a single-piece AcrySof intraocular lens (IOL) that exhibits glistening formations. The pr...
Eligibility Criteria
Inclusion
- Presence of obvious glistenings by slit lamp exam
- Best spectacle corrected visual acuity of 20/20 or better on the Snellen chart at most recent exam
Exclusion
- Any central corneal pathology that could have impact on vision other than mild guttata felt unlikely to have any impact on corneal clarity.
- Any documented glaucoma of any kind.
- Any macular pathology except minimal drusen without retinal pigment epithelial pathology felt to be consistent with normal vision.
- Any diabetic retinopathy other than minimal background diabetic retinopathy felt unlikely to affect vision.
- Any other cause of central visual acuity loss including optic nerve, occipital cortex dysfunction or amblyopia.
- Diagnosis of dry eye syndrome, defined as any corneal staining with fluorescein
- Presence of any central posterior capsular opacification. Previous YAG laser capsulotomy is allowed.
- Any surgical complication having to do with the capsule such as a broken capsule or zonular dialysis or iris trauma or any other complication felt to in any way impact upon the quality of the visual result.
- Any contraindication to pupil dilation
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01202981
Start Date
July 1 2010
End Date
June 1 2013
Last Update
December 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah, John Moran Eye Center
Salt Lake City, Utah, United States, 84132